http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-258999-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e8a130d33829f2bd4e42bbc14c00d4a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-18 |
| filingDate | 1998-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b596b5dd6c95903e0bf43a19bb999b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3ee2a17e1b980a9e5c88fe279fc74ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28f73130e1943910fcc63d6c260ffb11 |
| publicationDate | 2000-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CZ-258999-A3 |
| titleOfInvention | Terbenzimidazoles and pharmaceutical composition |
| abstract | Formula (I) Inhibitoprostororases, wherein Ar is atyl ornnitrogen, sulfur or oxygen heteroaromatic group; Xjenhydrogen, CN, CHO, OH, acetyl, CF 3, C 1 -C 6 alkyl,nNU, NUhalogen, or halo / C 1-6 alkyl; each group meansnindependently hydrogen, C1-6alkyl or aralkyl; Y is phenyl ornmethoxyphenyl; each Z is independently hydrogen, Q.n4 / alkyl, halogen or halo / C 1-4 / all; an is 0 or 1; they are notna pharmaceutically acceptable salt for use in medicine, e.g.ntreatment of fungal infections or tumor growth. They describe themselvesnalso compounds of formula I and pharmaceutical compositions containing themnof said compounds. |
| priorityDate | 1998-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 190.